Physician profile
Mohsin S Sheikh
NPI 1417151259
$2,057.33
in general payments reported to CMS, 2019-2025
21 companies · $791 in 2025
The $791 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $74.08 · 2022: $158 · 2023: $172 · 2024: $606 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $991.26 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $211.83 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Mml US, INC. | $204.90 | 2024 | Reactiv8 |
| Abbvie INC. | $91.82 | 2023-2025 | Botox |
| Globus Medical, INC. | $89.87 | 2025 | Senza, Vyrsa V1 |
| Curonix LLC | $53.00 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $47.23 | 2024-2025 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $45.29 | 2024-2025 | Iovera, Zilretta |
| Amgen INC. | $38.88 | 2019 | |
| Electronic Waveform Lab, INC. | $35.17 | 2025 | |
| Collegium Pharmaceutical, INC. | $34.11 | 2019-2024 | Xtampza |
| Medtronic USA, INC. | $30.57 | 2020 | |
| Allergan, INC. | $29.50 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $25.50 | 2025 | Kristalose |
| Vertex Pharmaceuticals Incorporated | $21.53 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.86 | 2025 | Relistor |
| Nevro Corp. | $20.08 | 2023 | Senza |
| Pacira Therapeutics, INC. | $19.56 | 2020 | |
| Horizon Therapeutics Plc | $18.45 | 2019 | |
| Scilex Pharmaceuticals INC. | $17.07 | 2019 | |
| Lilly USA, LLC | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohsin Sheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.